|
⚲
|
| Keyboard |
| Catalio Capital Management LP
✚
|
|
|---|---|
| CRD # | 310374 |
| SEC # | 801-121976 |
| CIK # | 0001958125 |
| AUM | 2,176.6 M (2026-03-31) |
| Employees | 30 (43% Investors, 0% Brokers) |
| Phone | 410-989-6168 |
| Address | 512 W 22nd Street New York, NY 10011 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($B) |
|---|
| CIK | Period |
|---|---|
| 0001958125 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Magenta Therapeutics Inc | 47.0 | ||
| Bridgebio Pharma Inc | 32.1 | ||
| Ascendis Pharma A/S | 29.5 | ||
| Bristol Myers Squibb Co | 25.5 | ||
| Syndax Pharmaceuticals Inc | 24.4 | ||
| Gilead Sciences Inc | 22.8 | ||
| MIND Medicine Mindmed Inc | 19.6 | ||
| Boston Scientific Corp | 18.8 | ||
| Ultragenyx Pharmaceutical Inc | 17.8 | ||
| Incyte Corp | 17.1 | ||
| Cytokinetics Inc | 14.2 | ||
| Natera Inc | 14.2 | ||
| Corvus Pharmaceuticals Inc | 13.0 | ||
| Structure Therapeutics Inc | 12.3 | ||
| Mineralys Therapeutics Inc | 11.9 | ||
| Edwards Lifesciences Corp | 11.6 | ||
| Veradermics Inc | 11.0 | ||
| Adaptive Biotechnologies Corp | 10.0 | ||
| Heartflow Inc | 9.8 | ||
| Uniqure NV | 8.0 | ||
| FS Development Corp | 7.9 | ||
| Septerna Inc | 7.1 | ||
| Abivax Sa | 5.3 | ||
| Dyne Therapeutics Inc | 5.1 | ||
| Tokai Pharmaceuticals Inc | 5.1 | ||
| Karyopharm Therapeutics Inc | 5.0 | ||
| Supernus Pharmaceuticals Inc | 3.2 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Catalio Genesis Fund IX LLC | [2026-03-31] | 8.6 M | 10.0 M |
| Offered $8,625,000 · Filed 2025-07-03 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Catalio Genesis Fund VIII LLC | [2026-03-31] | 15.2 M | 14.5 M |
| Offered $15,247,500 · Filed 2025-04-16 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Catalio Genesis Fund VI LLC | [2026-03-31] | 15.5 M | 14.8 M |
| Offered $15,497,500 · Filed 2025-04-16 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| Other | Catalio Inflection Fund I LLC | [2026-03-31] | 12.5 M | 12.9 M |
| Offered $12,500,000 · Filed 2025-04-10 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Minimum $50,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Catalio Access Fund VII LLC | [2025-03-28] | 5.0 M | 5.7 M |
| Offered $5,000,000 · Filed 2024-06-26 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Catalio Genesis Fund V LLC | [2025-03-28] | 11.5 M | 12.1 M |
| Offered $11,480,000 · Filed 2024-05-17 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| Other | Catalio Structured Opportunities Fund II LP | [2025-03-28] | 63.5 M | 143.5 M |
| Filed 2025-01-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $1,480,000 · Revenue Decline to Disclose | ||||
| Other | Catalio Structured Opportunities Offshore Fund II LP | [2025-03-28] | 36.9 M | 81.3 M |
| Filed 2025-01-06 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $1,000,000 · Remaining Indefinite · Duration More than one year · Commission $1,480,000 · Revenue Decline to Disclose | ||||
| PE | Catalio Nexus Fund IV LP | [2024-03-26] | 357.6 M | 348.9 M |
| Filed 2026-01-07 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | Catalio Public Equities Master Fund LP | [2024-03-26] | 142.1 M | 161.6 M |
| Filed 2026-02-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 1 | 0.2 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 26 | 1.4 |
| (g) Pension and profit sharing plans | 1 | 0.0 |
| (h) Charitable organizations | 1 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 2 | 0.2 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 1 | 0.0 |
| (n) Other | 1 | 0.2 |
| Total | 33 | 2.2 |
| By Discretionary | ||
| Discretionary | 31 | 1.9 |
| Non-Discretionary | 2 | 0.2 |
| Total | 33 | 2.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.7 | |
| United States Persons | 1.5 | |
| Total | 33 | 2.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Abali Hoilett | Director | 137 | 35 | |
| Peter Huber | Director | 88 | 22 | |
| Kim Bishop | Director | 50 | 17 | |
| Christine Clarke | Executive Officer | 56 | 5 | |
| Arthur Cohen | Executive Officer | 57 | 4 | |
| Joseph Healey | Executive Officer | 54 | 4 | |
| LP HealthCor Management | Executive Officer | 46 | 3 | |
| David Warnock | Director | 33 | 3 | |
| Joseph Sherman | Director | 21 | 3 | |
| R Vogelstein | Director, Executive Officer | 17 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001958125] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 549300P3CYP9WVN0M608 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Varadero Capital LP
✚
|
NY | 2,292.2 M |
|
Waratah Capital Advisors Ltd
✚
|
2,271.0 M | |
|
Coliseum Capital Management LLC
✚
|
CT | 2,269.4 M |
|
Teng Yue Partners LP
✚
|
NY | 2,247.5 M |
|
Mason Capital Management LLC
✚
|
NY | 2,237.5 M |
|
FEG Investment Services LLC
✚
|
OH | 2,230.7 M |
|
LUPA RIA Investment Management LLC
✚
|
NY | 2,189.3 M |
|
RP Management LLC
✚
|
NY | 2,139.0 M |
|
Albion River Management LLC
✚
|
MD | 2,062.2 M |
|
Flat Footed LLC
✚
|
WY | 2,059.5 M |